Literature DB >> 18350594

Gastric cancer: animal studies on the risk of hypoacidity and hypergastrinemia.

Reidar Fossmark1, Gunnar Qvigstad, Helge-L Waldum.   

Abstract

Gastric hypoacidity and hypergastrinaemia are seen in several conditions associated with an increased risk of gastric malignancy. Hypoacidity and hypergastrinaemia are closely related and their long-term effects are difficult to study separately in patients. Studies using animal models can provide valuable information about risk factors and mechanisms in gastric cancer development as the models allow a high degree of intervention when introducing or eliminating factors possibly affecting carcinogenesis. In this report, we briefly review findings from relevant animal studies on this topic. Animal models of gastric hypoacidity and hypergastrinaemia provide evidence hypergastrinaemia is a common causative factor in many otherwise diverse settings. In all species where sufficient hypoacidity and hypergastrinaemia have been induced, a proportion of the animals develop malignant lesions in the gastric oxyntic mucosa.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18350594      PMCID: PMC2695903          DOI: 10.3748/wjg.14.1646

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  77 in total

1.  Safety of proton pump inhibitors.

Authors:  H L Waldum; E Brenna; T C Martinsen
Journal:  Aliment Pharmacol Ther       Date:  2000-11       Impact factor: 8.171

2.  Regulation of gastric epithelial cell development revealed in H(+)/K(+)-ATPase beta-subunit- and gastrin-deficient mice.

Authors:  T V Franic; L M Judd; D Robinson; S P Barrett; K L Scarff; P A Gleeson; L C Samuelson; I R Van Driel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-12       Impact factor: 4.052

3.  Expression and cell-specific localization of the cholecystokinin B/gastrin receptor in the human stomach.

Authors:  H Kulaksiz; R Arnold; B Göke; E Maronde; M Meyer; F Fahrenholz; W G Forssmann; R Eissele
Journal:  Cell Tissue Res       Date:  2000-02       Impact factor: 5.249

4.  Synergistic interaction between hypergastrinemia and Helicobacter infection in a mouse model of gastric cancer.

Authors:  T C Wang; C A Dangler; D Chen; J R Goldenring; T Koh; R Raychowdhury; R J Coffey; S Ito; A Varro; G J Dockray; J G Fox
Journal:  Gastroenterology       Date:  2000-01       Impact factor: 22.682

5.  The CCK-2 receptor is located on the ECL cell, but not on the parietal cell.

Authors:  I Bakke; G Qvigstad; A K Sandvik; H L Waldum
Journal:  Scand J Gastroenterol       Date:  2001-11       Impact factor: 2.423

6.  Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa.

Authors:  F Schmitz; M N Göke; J M Otte; H Schrader; B Reimann; M L Kruse; E G Siegel; J Peters; K H Herzig; U R Fölsch; W E Schmidt
Journal:  Regul Pept       Date:  2001-12-15

7.  Abnormal functional and morphological regulation of the gastric mucosa in histamine H2 receptor-deficient mice.

Authors:  T Kobayashi; S Tonai; Y Ishihara; R Koga; S Okabe; T Watanabe
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

Review 8.  Lessons from the gastrin knockout mice.

Authors:  Lennart Friis-Hansen
Journal:  Regul Pept       Date:  2006-12-16

9.  Carcinogenic hypergastrinemia: signet-ring cell carcinoma in a patient with multiple endocrine neoplasia type 1 with Zollinger-Ellison's syndrome.

Authors:  Matthias Schott; Cornelia Sagert; Holger S Willenberg; Sven Schinner; Uwe Ramp; Andrea Varro; Andreas Raffel; Claus Eisenberger; Kai Zacharowski; Aurel Perren; Werner A Scherbaum
Journal:  J Clin Endocrinol Metab       Date:  2007-07-03       Impact factor: 5.958

10.  Helicobacter and gastrin stimulate Reg1 expression in gastric epithelial cells through distinct promoter elements.

Authors:  Islay A Steele; Rod Dimaline; D Mark Pritchard; Richard M Peek; Timothy C Wang; Graham J Dockray; Andrea Varro
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2007-04-26       Impact factor: 4.052

View more
  6 in total

1.  Adenocarcinoma arising in multiple hyperplastic polyps in a patient with Helicobacter pylori infection and hypergastrinemia during long-term proton pump inhibitor therapy.

Authors:  Hajime Anjiki; Ken-Ichi Mukaisho; Yu Kadomoto; Hisakazu Doi; Kunio Yoshikawa; Takahisa Nakayama; Diem Thi-Ngoc Vo; Takanori Hattori; Hiroyuki Sugihara
Journal:  Clin J Gastroenterol       Date:  2017-02-03

2.  Human gastrin mRNA expression up-regulated by Helicobacter pylori CagA through MEK/ERK and JAK2-signaling pathways in gastric cancer cells.

Authors:  Jianjiang Zhou; Yuan Xie; Yan Zhao; Shu Wang; Yu Li
Journal:  Gastric Cancer       Date:  2011-04-22       Impact factor: 7.370

3.  Gastric cancer in patients with type I gastric carcinoids.

Authors:  Edith Lahner; Gianluca Esposito; Emanuela Pilozzi; Gloria Galli; Vito D Corleto; Emilio Di Giulio; Bruno Annibale
Journal:  Gastric Cancer       Date:  2014-06-03       Impact factor: 7.370

4.  Application of a novel method of double APAAP staining with subsequent quantitative image analysis to the examination of integrin expression in undifferentiated-type gastric carcinomas.

Authors:  Natalia Yanchenko; Hiroyuki Sugihara; Takanori Hattori
Journal:  J Histochem Cytochem       Date:  2009-08-17       Impact factor: 2.479

5.  A knockin mouse model for human ATP4aR703C mutation identified in familial gastric neuroendocrine tumors recapitulates the premalignant condition of the human disease and suggests new therapeutic strategies.

Authors:  Oriol Calvete; Andrea Varro; D Mark Pritchard; Alicia Barroso; Marta Oteo; Miguel Ángel Morcillo; Pierfrancesco Vargiu; Steven Dodd; Miriam Garcia; José Reyes; Sagrario Ortega; Javier Benitez
Journal:  Dis Model Mech       Date:  2016-08-04       Impact factor: 5.758

6.  A New Method for Early Screening of Gastric Cancer (G17 and CA724 Dual-Labeled Time-Resolved Fluorescence Immunoassay).

Authors:  Chang Liu; Cuicui Chen; Hongrui Lai; Huankun Liang; Shuhai Zhong; Guiling Guo; Lei Wang; Laiqing Li
Journal:  Comput Math Methods Med       Date:  2022-07-20       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.